
Corcept Therapeutics Inc (CORT) receives a Buy rating from Truist
Corcept Therapeutics Inc’s recently made public that its Officer Robb Gary Charles acquired Company’s shares for reported $0.23 million on
Corcept Therapeutics Inc’s recently made public that its Officer Robb Gary Charles acquired Company’s shares for reported $0.23 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Corcept Therapeutics Inc’s recent filing unveils that its Officer BELANOFF JOSEPH K acquired Company’s shares for reported $3.1 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Corcept Therapeutics Inc’s filing revealed that its Chief Business Officer Robb Gary Charles unloaded Company’s shares for reported $0.17 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corcept Therapeutics
Corcept Therapeutics Inc’s filing revealed that its Director MAHONEY DAVID L acquired Company’s shares for reported $2.03 million on May
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or